Zomato founder Deepinder Goyal has committed $25 million of his personal wealth to fund Continue Research, a longevity-focused venture exploring simpler biological levers to extend human life. The initiative aims to support global researchers challenging conventional ageing models and developing practical health tracking solutions.
Deepinder Goyal, CEO of Eternal and founder of Zomato, has infused $25 million of his own capital into Continue Research—a venture dedicated to decoding the biology of human ageing. The announcement, made on October 24, 2025, marks a significant milestone in India’s private research ecosystem, blending entrepreneurial vision with scientific ambition.
Important Points
- Continue Research began two years ago as a hypothesis-driven effort to identify “simple levers” in human biology that could alter ageing and lifespan
- Goyal’s funding will support global researchers who challenge complex ageing models and propose practical, scalable interventions
- The initiative is rooted in the belief that the human body, like any system, has leverage points that can be adjusted for longevity
- Goyal stated, “We are at the tail-end of the research on this hypothesis, which if true, could fundamentally change our understanding of biology and ageing”
- The fund will provide grants to scientists working on health tracking, mental wellness, and biological simplification
- Continue Research is backed entirely by Goyal’s personal corpus of ₹220 crore ($25 million), with no external investors involved
- The venture reflects a growing trend of Indian entrepreneurs investing in frontier science and public health innovation
- Goyal’s long-term goal is to raise average lifespans to 180+ years, making longevity accessible to the general population
This bold investment signals a shift in how tech leaders are approaching health and ageing—not just as business opportunities, but as transformative missions. Continue Research could emerge as a key player in global longevity science, with India at its helm.
Sources: Moneycontrol, CNBC-TV18, Hindustan Times, Economic Times